Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. Amarantus Bioscience Holdings (AMBS) Message Board

Let's get some more SeD background, since discomfo

Message Board Public Reply | Private Reply | Keep | Replies (0)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 30070
(Total Views: 437)
Posted On: 09/13/2017 2:06:42 AM
Avatar
Posted By: freegriff
Let's get some more SeD background, since discomfort remains about our partner, and only knowledge will alleviate or affirm: The recent turnaround chronology for SeD. Please note, since this was published, and per lat filings, CHF is now close to 2/3 complete ownership. http://sed.com.sg/content/uploads/2017/09/201...Charts.pdf

And some additional knowlegde on the SeD audit change. SeD changed their accountants because now instead of a capable group at EY, or a more senior group at MS, they are now going to directly work with the #1 and esp. #2 guy, the Senior partner Robin Chin of FKT, which is a major firm. See his specialties here:

Robin Chin
Senior Partner / International Business Partner, Foo Kon Tan LLP

Robin is senior partner with a wealth of experience spanning more than 28 years. With his keen understanding and sensitivity to global business and cultural differences, he is the firm’s key ‘go-to’ professional for clients seeking to establish international footprints in the regional and global markets. He provides comprehensive support and guides the firm’s international as well as Singapore based clients desiring to expand overseas. He is involved in various aspects of assurance advisory with a special focus on implications for both corporate governance and restructuring, IPO, RTO and financial investigations. He has done public listings on SGX, ASX AIM. Additionally, he has conducted significant financial investigations for both local and overseas clients both listed as well as privately held businesses. He is also principally responsible for the firm’s People and Culture policy matters.



(2)
(0)




Amarantus Bioscience Holdings (AMBS) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  






Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us